- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
Pfizer acquired Biohaven's migraine business, requiring FDA approval for the resulting drug launch.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer acquired Biohaven's migraine business, requiring FDA approval for the resulting drug launch.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- FDA accepted Pfizer's New Drug Application (NDA) for vepdegestrant, supporting the company's growth trajectory.Sub-event
Pfizer acquired Biohaven's migraine business, necessitating FDA approval for the drug launch.1 source
Keep exploring
Part of
A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Also in this story
- A partnership with BARDA has accelerated the development of SCY-247 for the company.
- A company plans to submit regulatory applications to the FDA, EMA, and Australian TGA.
- Approval leads to procurement process initiation.
- UroGen Pharma Ltd., headquartered in Princeton, is seeking FDA approval for its products for the U.S. market.
The entities involved
Related events
- FDA and Pfizer are seeking regulatory approval for their products.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- Roivant Sciences licensed a drug from Pfizer for regulatory approval.
- The FDA recommended advancement for a new drug application submitted by a company.
- BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.
Coverage
Newest first; wire copies grouped- BioPharma DiveBiohaven’s rare disease drug is ‘ready to ship on Day 1’ following FDA approval This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily